Prostate Cancer

The incidence rate for prostate cancer in the UK is higher than in Europe - 111.1 per 100,000 of the population in the UK and 105.5 per 100,000 of the population on average in Europe. In comparison to the other EURO4 countries, the UKs incidence rate is lower than Germany and France.

EUCAN, Cancer factsheets, 2012. Available at http://eco.iarc.fr/EUCAN

The mortality rate for prostate cancer in the UK is markedly higher than in Europe. While the European average mortality rate for this type of cancer is 18.9 per 100,000 of the population, the UKs average is 22.8 per 100,000 of the population. In comparison to the other EURO4 countries, the UK has the highest mortality rate for this type of cancer.

World Health Organisation, Cancer Mortality database, 2012. Available at http://www-dep.iarc.fr/WHOdb/WHOdb.htm

The five-year survival rate for prostate cancer in the UK is markedly lower than in Europe. While the European average five-year survival rate for this type of cancer is 84%, the UKs is 78%. In comparison to the other EURO4 countries, the UK has the worst survival rate for this type of cancer.

EUROCARE, database 5, 2014. Available at http://www.eurocare.it/Database/tabid/77/Default.aspx
EUROCARE, Data and methods, 2014. Available at https://w3.iss.it/site/EU5Results/docs/Documentation_on_data_and_methods.pdf

Patient Experience

When compared to other cancers, patient experience for prostate cancer patients in the UK presents a mixed picture.

According to the 2015 National Cancer Patient Experience Survey, which surveyed over 100,000 cancer patients in the UK, prostate cancer patients rated the speed of diagnosis and understanding of their condition better than patients with other types of cancer.

However, one in five men with prostate cancer stated that they did not understand the treatment options available to them, suggesting that further improvements need to be made in increasing patient awareness of the advantages and disadvantages of different treatments options.